BioAge Labs (BIOA) Net Cash Flow (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Net Cash Flow data on file, last reported at $52.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 154.64% year-over-year to $52.9 million; the trailing twelve-month figure through Mar 2026 stood at -$15.6 million (down 119.48% YoY), and the FY2025 full-year result was -$165.4 million, down 150.22% from the prior year.
• Net Cash Flow improved to $52.9 million in Q1 2026, from -$26.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $175.4 million in Q3 2024 to a low of -$96.9 million in Q1 2025.
• A 4-year average of $20.7 million and a median of -$7.1 million in 2023 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow soared 307.51% in 2024 and sank 235.1% in 2025, its largest moves.
• Tracing BIOA's Net Cash Flow over 4 years: stood at -$9.5 million in 2023, then surged by 307.51% to $19.7 million in 2024, then slumped by 235.1% to -$26.7 million in 2025, then jumped by 298.44% to $52.9 million in 2026.
• Business Quant data shows BIOA's Net Cash Flow at $52.9 million in Q1 2026, -$26.7 million in Q4 2025, and -$4.7 million in Q3 2025.